Both in Pharmaceuticals
CNS Pharmaceuticals vs Skye Bioscience
Over the past year CNSP returned −44.8% and SKYE returned −94.9%; their daily moves had a correlation of 0.00.
CNSP −44.8% SKYE −94.9%Growth of $1, one year, split-adjusted
| Metric | CNSP | SKYE |
|---|---|---|
| Price | $4.91 | $1.59 |
| Market cap | $7.2M | $7.0M |
| Today | −3.97% | −1.24% |
| 1 month | −11.1% | −10.4% |
| 6 months | +116.2% | −66.5% |
| Year to date | −6.5% | −73.5% |
| 1 year | −44.9% | −95.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $20.0M | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 74.8% | 616.5% |
| Short % of float | 0.2% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).